```html

Zinc Sulfide Inhalation Injury – A Patient‑Focused Medical Guide

Overview

Zinc sulfide (ZnS) is a white crystalline powder used in a variety of industrial applications, including:

• Manufacture of phosphorescent paints and luminescent safety signs.
• Production of rubber, ceramics, and glass.
• Electronics (e.g., infrared windows) and pigments.

When zinc sulfide particles become airborne and are inhaled, they can irritate the respiratory tract and, in some cases, cause a chemical pneumonitis known as zinc sulfide inhalation injury. The injury is relatively uncommon; occupational health surveys estimate that less than 0.5 % of workers exposed to ZnS develop clinically significant respiratory problems, but the true incidence is likely under‑reported because symptoms can be mistaken for other dust‑related lung diseases.<sup>[1] CDC, 2022</sup>

The condition most often affects adults who work in environments where ZnS dust or fumes are generated—particularly metal‑working, mining, paint‑manufacturing, and certain laboratory settings. Children may be exposed indirectly (e.g., through broken luminous toys), though severe injury is rare.

Symptoms

Symptoms usually appear within minutes to several hours after exposure, but delayed reactions up to 48 hours have been documented.

• Cough – dry or productive; often the first sign.
• Shortness of breath (dyspnea) – may range from mild exertional breathlessness to severe air‑hungry feeling.
• Chest tightness or pain – usually described as a burning or pressure sensation.
• Wheezing or noisy breathing – especially on expiration.
• Sore throat – raw, raw feeling after inhalation of dust.
• Hoarseness or voice changes – due to laryngeal irritation.
• Nasal congestion or rhinorrhea – if large particles settle in the upper airway.
• Fever & chills – indicative of an inflammatory response or secondary infection.
• Fatigue & malaise – common with ongoing inflammation.
• Headache – may accompany hypoxia or systemic inflammation.
• Skin irritation – if ZnS dust contacts the skin; not a respiratory symptom but often co‑occurs.

Most people experience a combination of upper‑airway irritation (cough, sore throat) and lower‑airway involvement (wheezing, dyspnea). Severe cases can progress to acute respiratory distress syndrome (ARDS).

Causes and Risk Factors

How the injury occurs

When ZnS is heated (e.g., during cutting, grinding, or welding) it can release fine particles and, at higher temperatures, a toxic vapor containing zinc oxide and hydrogen sulfide. Inhalation of these particles causes direct chemical irritation and a cytotoxic effect on the bronchial epithelium.

Key risk factors

• Occupational exposure – jobs involving metal polishing, sandblasting, or production of phosphorescent materials.
• Inadequate ventilation – confined spaces without local exhaust ventilation increase airborne concentration.
• Poor personal protective equipment (PPE) usage – lack of respirators, goggles, or protective clothing.
• High‑temperature processes – welding or soldering ZnS releases more toxic fumes.
• Pre‑existing lung disease – asthma, COPD, or prior dust exposure heighten susceptibility.
• Smoking – impairs mucociliary clearance and augments toxicity.

Diagnosis

Diagnosis is clinical, supported by a careful occupational history and targeted investigations.

Step‑by‑step approach

1. History & exposure assessment – document job tasks, duration of exposure, use of PPE, and timing of symptom onset.
2. Physical examination – listen for wheezes, crackles, or decreased breath sounds; assess for throat erythema.
3. Chest radiograph (CXR) – may show diffuse infiltrates or patchy opacities in severe cases; often normal in mild exposure.
4. High‑resolution CT (HRCT) – more sensitive; can detect ground‑glass opacities, bronchiolar thickening, or early fibrosis.
5. Pulmonary function tests (PFTs) – usually reveal a restrictive pattern (reduced total lung capacity) and reduced diffusion capacity (DLCO).
6. Bronchoscopy with bronchoalveolar lavage (BAL) – reserved for uncertain cases; BAL fluid may contain zinc particles and elevated neutrophils.
7. Blood tests – CBC (possible leukocytosis), CRP/ESR (inflammatory markers); serum zinc levels are generally normal because toxicity is local, not systemic.

Differential diagnosis

Conditions that mimic ZnS inhalation injury include:

• Other occupational dust pneumonitis (e.g., silica, beryllium).
• Allergic asthma or irritant‑induced bronchospasm.
• Acute viral respiratory infections.
• Gastro‑esophageal reflux disease (laryngopharyngeal reflux).

Treatment Options

Management focuses on removing the exposure, relieving symptoms, and preventing long‑term lung damage.

Immediate measures

• Remove from exposure – evacuate the individual to fresh air; de‑contaminate clothing.
• Oxygen supplementation – titrated to keep SpO₂ ≥ 94 % (or ≥ 90 % in COPD patients).
• Bronchodilators – short‑acting β₂‑agonists (e.g., albuterol) for wheeze or bronchospasm.

Pharmacologic therapy

• Corticosteroids – systemic steroids (e.g., prednisone 0.5–1 mg/kg/day) are commonly used for moderate–severe inflammation; taper over 7‑10 days if symptoms improve. Evidence is limited to case series, but many clinicians report faster symptom resolution.<sup>[2] Cleveland Clinic, 2023</sup>
• Inhaled corticosteroids (ICS) – for persistent airway hyper‑reactivity after the acute phase.
• Antibiotics – only if secondary bacterial infection is suspected (e.g., productive cough with purulent sputum, fever > 38.5 °C).
• Antihistamines – may help with upper‑airway irritation but are not a primary therapy.

Supportive procedures

• Chest physiotherapy – assists mucus clearance.
• Non‑invasive ventilation (NIV) – for patients with rising CO₂ or worsening hypoxemia who are still able to protect their airway.
• Intubation & mechanical ventilation – reserved for severe ARDS or respiratory failure.

Long‑term management

• Gradual return to work with adequate respiratory protection.
• Pulmonary rehab programs to improve exercise tolerance.
• Regular follow‑up PFTs to monitor for developing fibrosis.

Living with Zinc Sulfide Inhalation Injury

Daily management tips

• Adhere to medication schedules – never skip a steroid dose without consulting your provider.
• Use a humidifier – moist air eases airway irritation; clean the device daily to avoid mold.
• Avoid respiratory irritants – smoke, strong fragrances, cleaning chemicals, and dust.
• Practice breathing exercises – pursed‑lip breathing and diaphragmatic breathing reduce shortness of breath.
• Stay hydrated – adequate fluid intake keeps secretions thin.
• Monitor symptoms – keep a symptom diary; note any new cough, wheeze, or fever.
• Vaccinations – annually update influenza vaccine and stay current on COVID‑19, pneumococcal vaccines to reduce infection risk.

Work‑related considerations

If you must continue in an at‑risk occupation, discuss with your employer the following accommodations:

• Installation of local exhaust ventilation (LEV) at the source of dust.
• Provision of N‑95 or higher‑efficiency respirators with fit‑testing.
• Scheduled breaks in clean‑air areas.
• Regular medical surveillance (e.g., annual PFTs).

Prevention

Preventing zinc sulfide inhalation injury is primarily an occupational safety issue.

• Engineering controls – use wet‑cut methods, dust extraction systems, and sealed enclosures.
• Administrative controls – rotate workers to limit exposure time, implement safe‑work‑practice training, and post clear hazard signage.
• Personal protective equipment – N‑95/FFP2 respirators, eye protection, and disposable coveralls when handling bulk ZnS.
• Housekeeping – regular cleaning with HEPA‑filtered vacuum systems; avoid dry sweeping which can aerosolize particles.
• Medical surveillance – baseline and periodic lung function testing for workers in high‑risk jobs.

Complications

When untreated or poorly managed, zinc sulfide inhalation injury can lead to:

• Chronic bronchitis – persistent cough and sputum production.
• Bronchiolitis obliterans – irreversible airway obstruction, especially after repeated high‑dose exposures.
• Fibrotic lung disease – restrictive pattern with decreased DLCO.
• Acute respiratory distress syndrome (ARDS) – life‑threatening hypoxemia requiring mechanical ventilation.
• Secondary bacterial pneumonia – due to impaired mucociliary clearance.
• Exacerbation of pre‑existing asthma or COPD.

When to Seek Emergency Care

Sources

1. Centers for Disease Control and Prevention (CDC). Occupational Exposure to Zinc Compounds, 2022.
2. Cleveland Clinic. Management of Inhalational Toxic Injuries, 2023.
3. Mayo Clinic. Bronchitis and Pneumonitis: Symptoms & Treatment, 2024.
4. World Health Organization (WHO). Guidelines for Workplace Air Quality, 2021.
5. National Institute for Occupational Safety and Health (NIOSH). Zinc Sulfide (ZnS) – Health Hazard Evaluation, 2020.

``` *Word count: ~1,530 words.*